openPR Logo
Press release

Hospital Acquired Disease Testing Market to Surpass US$ 2.7 Billion by 2025 Globally, with Favorable Reimbursement Policies and Supporting Initiatives

02-01-2018 02:06 PM CET | Health & Medicine

Press release from: Clinical Diagnostic Report By CMI

Hospital Acquired Disease Testing Market to Surpass US$ 2.7

Hospital acquired Disease Testing – Hospital or Mortuary

Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients occurred due to adverse reaction caused by infectious toxin agents under medical care and were absent at the time of admission. Hospitals acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Pathogens responsible for nosocomial infections include viruses, fungal parasites, and bacteria.

Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management

Hospital acquired disease could be catheter-related blood stream infection, surgical site infection, ventilator-associated pneumonia, and catheter-associated urinary tract infection. These infection occurring in emerging economies globally. According Asia Pacific Journal of Tropical Medicine, 2017, Nosocomial infections account for around 10% in emerging economies and around 7% in developed economies out of all the infections. According to the World Health Organization (WHO), 2011, approximately around 15% patients hospitalized suffer from above mentioned infections, due to exposure to pathogens through different sources, such as healthcare staff and infected patients. Newborns, especially in emerging economies are also at high risk to develop hospital acquired infection. According to WHO, 2011, the infection rate in newborns is 20 times higher in emerging economies as compared to high income economies.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/992

Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management. Nosocomial infections could be prevented by practicing infection control programs and adopting antimicrobial control policies. For instance, National Health & Medical Research Council Australia (NHMRC), 2002 provided critical guidelines for the management of infections, prevention, and control in healthcare organizations.

The global hospital acquired disease testing market was valued at US$ 539 million in 2016 and is expected to witness a robust CAGR of 19.70% over the forecast period (2017 - 2025).

Antibodies resistance and extended hospitalization is expected to propel the growth of hospital acquired disease testing in near future

The most common nosocomial infections across the globe are the surgical wounds, urinary tract infections, and lower respiratory tract infections. The highest prevalence of these infections occurs in intensive care units, orthopedic, and acute surgical ward. Out of the mentioned infections, the urinary tract infections is the most common in the patients dwelling with urinary catheter, due to urethra is located close to the anus, which increases the changes of invasions of bacteria from large intestine into the urinary tracts. Due to these infections, the costs and the antibiotic resistance increases with extended hospitalization, which in turn expected to propel the growth of hospital acquired disease testing market. The popular techniques used for preventions, diagnosis, and testing of hospital acquired diseases are microarray, PCR, and solid phase hybridization.

Click here to know more about this publish report: https://www.coherentmarketinsights.com/market-insight/hospital-acquired-disease-testing-market-992

North America and Europe are expected to dominate the hospital acquired disease testing market owing to encouraging government initiatives, regulatory guidelines and reimbursement scenario. Medicare and private insurance companies are eliminating the reimbursement rate due to high rate of hospital acquired infection (HAI) incidence during 2014 and 2015, adding economic pressures on hospitals to reduce hospital acquired diseases. Ion the other hand, unhygienic conditions and practices in developing and underdeveloped economies is resulting in higher incidences of HAI in these regions. Thus, generating a need for HAI testing in this regions during the forecast period.

The key market players are Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid & others.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit our news Website: http://www.coherentchronicle.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hospital Acquired Disease Testing Market to Surpass US$ 2.7 Billion by 2025 Globally, with Favorable Reimbursement Policies and Supporting Initiatives here

News-ID: 927166 • Views: 237

More Releases from Clinical Diagnostic Report By CMI

Sepsis Diagnostic Market-Global Industry Insights, Trends, Outlook
Sepsis is life threatening complication caused due to the infection, which can result into organ failure, tissue damage, and ultimately lead to death if left untreated. If sepsis progresses to septic shock, it cause sudden drop in blood pressure and may leads to death of patient. Sepsis occurs due the infection in any part of the body. However the most common site of infections leading to the sepsis are lungs,
Liquid Biopsy Market - Insights
Liquid biopsy involves testing of the blood to identify biomarkers or cancer cells in the form of cells or pieces of DNA which are separated from the tumor and are circulating in the blood. Liquid biopsy helps in early detection of cancer, which would aid in adopting an optimal treatment plan. It is a non-invasive technique, which makes frequent testing possible, and effectiveness of cancer treatment can also be validated
Enteric Disease Testing Market - Global Industry Insights 2025
Enteric infection is a type of intestinal disease that causes symptoms ranging from mild gastroenteritis to systemic infections and severe diarrhea. According to WHO in 2017, Infectious gastroenteritis accounts for 1 billion cases of diarrhea globally and over 2 million deaths annually. In addition to this, according to Bill and Melinda Gates Foundation, 2017, enteric and diarrheal diseases leads to death of about 500,000 children, under the age of five
In Vitro Diagnostics (IVD) Market Size to Soar Past US$ 25 Billion by 2024
In vitro diagnostics are diagnostic devices and equipment that extract vital information about an individual or patient after a sequence of tests. Introduction of novel diagnostics test applications on the backdrop of advancements and innovations in the IVD technologies by various organizations has resulted in rampant growth of the in vitro diagnostics (IVD) market, which is expected to sustain in the near future. Diagnoses and tests are precursors to any

All 5 Releases


More Releases for Hospital

Hospital-based EMR Market
Electronic medical record (EMR) is a digital version of a paper chart, which contains a patient's medical history. This system is designed to share information with other healthcare providers such as laboratories and specialists. It helps to reduce operational cost such as transcription services and overtime labor expenses. Get Sample PDF of Report@ https://www.alliedmarketresearch.com/request-toc-and-sample/3219 Increase in demand for advanced health monitoring systems drives the growth of the market. In addition, rise in
Hospital Logistics Robots Market 2018
Hospital logistics robots comprise autonomous guided vehicles (AGVs) and mobile robot platforms. These are used for managing the flow of goods such as laboratory samples, food, pharmaceuticals, environmental waste, and laundry inside hospital premises. Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-hospital-logistics-robots-2018-2023-863 This report focuses on the Hospital Logistics Robots in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based
Hospital Privacy Screens
Business NEWS 2018 : Hospital Privacy screens are designed to provide privacy and protection and create more pleasant environment for patients in private clinics, hospitals, nursing homes, and specialty care centers. It is one of the best alternatives to the curtains, which is the source of infection that cannot be cleaned regularly, as its hard surface can be wiped and disinfected regularly, thus eliminating the need to remove, launder, and
Lotus Eye Care Hospital
Lotus Eye Care Hospital Lotus Eye Care Hospital- Company Profile & Financial Analysis” contains in depth information and data about the company and its operations. You will find information on the business structure, areas of operation, products and services offered by the company. It also comprises SWOT analysis, key ratios, historical financial data and insider’s view on financial stability and industrial ranking with financial forecasts for two- year period. This report is
Neuromed hospital grows
Mitsubishi Electric Hydronics & IT Cooling Systems, with its brand Climaveneta, provided air conditioning units to the new clinic belonging to Neuromed Institute in Italy, after having successfully supplied other units to the same hospital in the past years. Five years after laying the first stone, the new clinic of the Neurology Institute was inaugurated on October 27th. The Hospital boasts a high degree of specialization in Neurosurgery, Neurology, and all
The Hospital undergoing surgery
Gustavo Frickle Hospital is a new 92,000 sqm building in Viña del mar, Chile. This modern 11-storey structure with 554 rooms, clinical wards and an heliport, will be inaugurated in March 2017. Providing patients and medical personnel with ideal temperature and humidity conditions as well as huge amount of sanitary hot water, achieving these with reduced acoustic emissions and highest efficiency, are the key challenges for the HVAC system of the